<DOC>
	<DOCNO>NCT01324167</DOCNO>
	<brief_summary>The investigator would like know association gene polymorphisms metabolic adversity clozapine-treated patient schizophrenia Taiwan .</brief_summary>
	<brief_title>Effects Gene Polymorphisms Metabolic Features Clozapine-treated Patients With Schizophrenia</brief_title>
	<detailed_description>The atypical antipsychotic , olanzapine , risperidone , quetiapine , ziprasidone , effective treat positive negative symptom schizophrenia ( Kelleher et al. , 2002 ) . However , atypical antipsychotic link several form morbidity , include obesity , hyperlipidemia , type 2 diabetes mellitus ( DM ) ( Bergman Ader , 2005 ; Jin et al. , 2004 ; Melkersson Dahl , 2004 ) . Compared general population , life expectancy schizophrenic patient shorter much 20 % , attributable high rate suicide , accidental death , natural cause cardiovascular disease DM ( Harris Barraclough , 1998 ) . Several study suggest metabolic abnormality may lead great vulnerability cardiovascular disease thus may contribute excessive mortality among schizophrenic patient .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>fulfil DSMIV criterion schizophrenia schizoaffective disorder 1865 year age receive clozapine least 6 month diabetes mellitus patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>schizoaffective disorder</keyword>
</DOC>